Dermatology Image: Erythema Multiforme

Dermatology Image: Erythema Multiforme

 

Joel T Levis, MD, PhD, FACEP, FAAEM

Fall 2011 - Volume 15 Number 4

https://doi.org/10.7812/TPP/11-115

Dermatology Image: Erythema Multiforme

Erythema multiforme (EM) is a type of delayed hypersensitivity skin reaction triggered by infection or certain drugs.1 It consists of a polymorphous eruption of macules, papules, and characteristics target lesions (central bullae or vesicle with surrounding concentric rash) distributed with a propensity for the distal extremities.2 Although the more severe conditions of Steven-Johnson Syndrome and toxic epidermal necrolysis (TEN) may represent the same process, EM, with its minimal mucous membrane involvement and less than 10% epidermal detachment, now is accepted as a distinct condition. Possible infectious causes of EM include herpes simplex virus (HSV), adenovirus, measles, mycobacterium, yersinia, and treponema pallidum.1 Medications most often associated with EM include barbiturates, hydantoins, nonsteroidal anti-inflammatory drugs, penicillins, phenothiazines, and sulfonamides.3 In more than 50% of cases of EM no underlying cause is found.1 EM is a clinical diagnosis. Skin biopsy is not necessary when the clinical picture is clear, as biopsy findings in EM are nonspecific.2 Management of EM involves determining the etiology, when possible, and treating the suspected infection or discontinuing the causal drug. Oral antihistamines and topical steroids may be used to provide symptom relief in mild cases of EM, whereas oral prednisone for one to two weeks followed by a taper may be used in patients with more severe presentations.4

References

1.    Loh KY. A 'target‘ skin lesion. Aust Fam Physician 2008 Nov;37(11):946.
2.    Lamoreux MR, Sternbach MR, Hsu WT. Erythema multiforme. Am Fam Physician 2006 Dec;74(11):1883-8.
3.    Volcheck GW. Clinical evaluation and management of drug hypersensitivity. Immunol Allergy Clin North Am 2004 Aug;24(3):357-71, v.
4.    Habif TB. Hypersensitivity syndromes and vasculitis. In: Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. New York: Mosby, 2004:626-34.

Circulation

25,000 print readers per quarter, 6900 eTOC readers, and in 2015, 1.4 million page views on TPJ articles in PubMed from a broad international readership

Subscriptions

The Permanente Journal (ISSN 1552-5767) is published quarterly by The Permanente Press. The Permanente Journal is available online (ISSN 1552-5775) at www.thepermanentejournal.org.

Letters

Articles, editorials, letters to the editor, and other material represent the opinion of the authors. Send your comments to permanente.journal@kp.org.


Copyright 2016 The Permanente Journal - Kaiser Permanente. All Rights Reserved.